indazoles has been researched along with Glaucoma, Suspect in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alisi, MA; Bettolo, RM; Cazzolla, N; Ceccacci, F; Furlotti, G; Garrone, B; Gasperi, T; La Bella, A; Leonelli, F; Loreto, MA; Magarò, G; Mangano, G; Masini, E; Miceli, M; Migneco, LM; Vitiello, M | 1 |
Chen, HH; Dean, TR; Glennon, RA; Hellberg, MR; Holt, WF; Kelly, CR; May, JA; McLaughlin, MA; Severns, BS; Sharif, NA; Young, R | 1 |
Dantanarayana, AP; May, JA; McLaughlin, MA; Sharif, NA; Zinke, PW | 1 |
3 other study(ies) available for indazoles and Glaucoma, Suspect
Article | Year |
---|---|
Targeting Serotonin 2A and Adrenergic α
Topics: Animals; Drug Discovery; Indazoles; Intraocular Pressure; Ocular Hypertension; Pyrazines; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship | 2018 |
Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-[(2S)-2-Aminopropyl]-8,9-dihydro-7H-pyrano[2,3-g]indazol-8-ol a Selective 5-HT2 Receptor Agonist.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cornea; Glaucoma; HT29 Cells; Humans; In Vitro Techniques; Indazoles; Indicators and Reagents; Intraocular Pressure; Macaca fascicularis; Ocular Hypertension; Permeability; Rats; Receptors, Adrenergic, alpha; Receptors, Serotonin; Serotonin 5-HT2 Receptor Agonists; Structure-Activity Relationship | 2015 |
1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Haplorhini; Head Movements; Humans; Indazoles; Lasers; Mice; Molecular Structure; Ocular Hypertension; Rabbits; Rats; Serotonin 5-HT2 Receptor Agonists | 2006 |